Anti-SEMA4D Monoclonal Antibody VX15/2503 With Nivolumab or Ipilimumab in Treating Patients With Stage III or IV Melanoma

Name: Anti-SEMA4D Monoclonal Antibody VX15/2503 With Nivolumab or Ipilimumab in Treating Patients With Stage III or IV Melanoma
License: Public Domain

Jonsson Comprehensive Cancer Center

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

metastatic melanoma, stage iii cutaneous melanoma ajcc v7, stage iiia cutaneous melanoma ajcc v7, stage iiib cutaneous melanoma ajcc v7, stage iiic cutaneous melanoma ajcc v7, stage iv cutaneous melanoma ajcc v6 and v7

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 640569
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.